(Q54064368)

24 May 2018

title

Assessment of human muscle glycogen synthesis and total glucose content by in vivo 13C MRS. (English)

1 reference

24 May 2018

author name string

Van Den Bergh AJ

1

1 reference

24 May 2018

Tack CJ

2

1 reference

24 May 2018

Van Den Boogert HJ

3

1 reference

24 May 2018

Vervoort G

4

1 reference

24 May 2018

Smits P

5

1 reference

24 May 2018

Heerschap A

6

1 reference

24 May 2018

publication date

1 February 2000

1 reference

24 May 2018

European Journal of Clinical Investigation

published in

1 reference

24 May 2018

volume

30

1 reference

24 May 2018

issue

2

1 reference

24 May 2018

page(s)

122-128

1 reference

24 May 2018

Hypertension and associated metabolic abnormalities--the role of insulin resistance and the sympathoadrenal system

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2000.00603.X

Lilly lecture 1987. The triumvirate: beta-cell, muscle, liver. A collusion responsible for NIDDM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2000.00603.X

Nuclear magnetic resonance studies of muscle and applications to exercise and diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2000.00603.X

In vivo regulation of muscle glycogen synthase and the control of glycogen synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2000.00603.X

Diagnosis of muscular glycogenosis by in vivo natural abundance 13C NMR spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2000.00603.X

Analysis of glycogen storage disease by in vivo 13C NMR: comparison of normal volunteers with a patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2000.00603.X

Direct observation of glycogen synthesis in human muscle with 13C NMR

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2000.00603.X

Evidence for 100% 13C NMR visibility of glucose in human skeletal muscle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2000.00603.X

13C/31P NMR studies of glucose transport in human skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2000.00603.X

Quantitation of muscle glycogen synthesis in normal subjects and subjects with non-insulin-dependent diabetes by 13C nuclear magnetic resonance spectroscopy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2000.00603.X

13C/31P NMR studies on the mechanism of insulin resistance in obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2000.00603.X

Mechanism of free fatty acid-induced insulin resistance in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2000.00603.X

Improvement in glucose tolerance and insulin resistance in obese subjects treated with troglitazone

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2000.00603.X

Metabolic effects of new oral hypoglycemic agent CS-045 in NIDDM subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2000.00603.X

New treatments for patients with type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2000.00603.X

Insulin-induced vasodilatation and endothelial function in obesity/insulin resistance. Effects of troglitazone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2000.00603.X

Decreased muscle glucose transport/phosphorylation is an early defect in the pathogenesis of non-insulin-dependent diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2000.00603.X

Hyperinsulinemia produces both sympathetic neural activation and vasodilation in normal humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2000.00603.X

Decreased effect of insulin to stimulate skeletal muscle blood flow in obese man. A novel mechanism for insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2000.00603.X

Metabolic effects of troglitazone monotherapy in type 2 diabetes mellitus. A randomized, double-blind, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2000.00603.X

Effects of Insulin on Blood Flow and Volume in Skeletal Muscle of Patients With IDDM: Studies Using [15O]H2O, [15O]CO, and Positron Emission Tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2000.00603.X

10.1046/J.1365-2362.2000.00603.X

21 January 2018

Identifiers

DOI

1 reference

24 May 2018

PubMed ID

10651836

1 reference

24 May 2018